Niagen Bioscience Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jan '26 Jan 29, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	404	392	97	117	225	243
Market Cap Growth	-5.94%	302.70%	-17.00%	-47.82%	-7.52%	6.28%
Enterprise Value	352	364	77	109	199	232
Last Close Price	4.74	5.20	1.32	1.49	3.26	3.88
PE Ratio	23.19	47.50	-	-	-	-
PS Ratio	3.80	4.08	1.29	1.74	3.79	5.02
PB Ratio	6.70	8.81	3.78	4.37	8.06	18.11
P/TBV Ratio	6.73	8.88	3.85	4.48	8.29	19.39
P/FCF Ratio	22.40	33.99	15.45	-	-	-
P/OCF Ratio	22.13	33.54	15.13	-	-	-
EV/Sales Ratio	3.36	3.78	1.01	1.62	3.35	4.79
EV/EBITDA Ratio	19.57	44.12	-	-	-	-
EV/EBIT Ratio	21.69	48.76	-	-	-	-
EV/FCF Ratio	19.55	31.54	12.17	-	-	-
Debt / Equity Ratio	0.04	0.06	0.12	0.15	0.15	0.10
Debt / EBITDA Ratio	0.14	0.27	-	-	-	-
Debt / FCF Ratio	0.14	0.22	0.47	-	-	-
Asset Turnover	1.61	1.62	1.53	1.29	1.40	1.51
Inventory Turnover	3.07	3.21	2.25	2.07	2.05	2.07
Quick Ratio	3.23	2.96	1.57	1.61	1.89	1.17
Current Ratio	4.12	3.57	2.40	2.61	2.78	1.96
Return on Equity (ROE)	38.90%	22.94%	-17.29%	-54.77%	-112.68%	-108.09%
Return on Assets (ROA)	15.60%	7.84%	-6.42%	-20.81%	-35.18%	-31.57%
Return on Invested Capital (ROIC)	221.46%	169.60%	-65.11%	-176.99%	-542.87%	-776.15%
Return on Capital Employed (ROCE)	25.60%	15.40%	-16.30%	-51.50%	-67.30%	-90.70%
Earnings Yield	4.31%	2.10%	-4.59%	-13.19%	-10.61%	-6.70%
FCF Yield	4.46%	2.94%	6.47%	-12.31%	-9.61%	-3.60%
Buyback Yield / Dilution	-10.80%	-4.19%	-7.54%	-3.79%	-10.02%	-7.03%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.